ChinaBio Today
Contributor since: 2007
Company: ChinaBio LLC
Articles
Week In Review: Innovent Lands $305 Million Investment From Sanofi; Will Partner Two Candidates In China
Sun, Aug. 7 RDPTF
Week In Review: China Biopharma Tops $2.8 Billion In Week's Dealmaking
Sun, Jul. 31 CSPCY, ELEV, LEGN
Week In Review: WuXi Biologics And WuXi AppTec Plan $2.8 Billion Investment In Singapore Facilities
Sun, Jul. 24 IVBIY, WUXAY, WUXIF
Week In Review: Qiming Closes $3.2 Billion For China Healthcare And Technology Investments
Sun, Jul. 17 BBSCF, BPMC, CNTB
Week In Review: Sequoia China Raises $9 Billion For Healthcare And Technology Investments
Mon, Jul. 11 BGNE, VIR1 Comment
Week In Review: Henlius Signs $196 Million Deal For 2 Oncology Bifunctional Sialidase Candidates
Sun, Jul. 3 ASCLF, ASPHF, BGNE
Week In Review: invoX, A Sino Biopharm Company, To Pay $161 Million To Acquire F-Star
Sun, Jun. 26 SBMFF, SBHMY, FSTX
Week In Review: Joincare Plans $300-$400 Million IPO On Swiss Exchange
Sun, Jun. 19 AZN, AZNCF, BNTX
Week In Review: Fosun Pays $158 Million For Controlling Stake In Singapore Medical Centers
Sun, Jun. 12 IMAB, SFOSF, SGBCF
Week In Review: Vivo Raises $600 Million In First Tranche Of China PE Fund
Sun, Jun. 5 AZN, AZNCF, GLAXF
Week In Review: Fosun Acquires VerImmune Cancer Immunotherapy In $125 Million Deal
Sun, May 29 CASBF, CASI, JNJ
Week In Review: Hengrui Launches U.S. Subsidiary To Bring Novel Medicines To Global Markets
Sun, May 22 BAYZF, MRK, RHHBY
Week In Review: Zhaoke Signs $130 Million Deal For Vision-Improving Eyedrops
Mon, May 16 ADOCY, ASCLF, CHRS
Week In Review: OrbiMed Plans To Raise $1.1 Billion For Fifth Asia Fund
Sun, May 8 AMGN, BGNE, CHRS
Week In Review: Wuhan Binhui Raises $47 Million For Oncolytic Virus Products
Sun, Apr. 24 TRVN, IMAB, AZN
Week In Review: VectorBuilder Plans $500 Million Gene Therapy Delivery CDMO In Guangzhou
Sun, Apr. 17 BGNE, VTGN1 Comment
Week In Review: Harbour BioMed Signs $350 Million Out-License Deal For Bispecific With AstraZeneca
Sun, Apr. 10 AZN, SLS1 Comment
Week In Review: RemeGen Raises $410 Million In Shanghai IPO For mAb/Dual Therapies
Sun, Apr. 3 REGMF, PYXS, LLY
Week In Review: Nuance In-Licenses RSV Vaccine In $225 Million Deal
Sun, Mar. 27 ASPHF, BNTX, LLY
Week In Review: A Possible Solution To U.S. De-Listing Of China Biopharmas?
Sun, Mar. 20 CHRS, IMAB
Week In Review: Adiso Breaks Out Of Stealth With $95 Million From Morningside
Mon, Mar. 14 BGNE, CYTO, HCM
Week In Review: Adagene Forms $2.5-Billion, Four-Drug Partnership With Sanofi
Sun, Mar. 6 ADAG, AQST, BLUE
Week In Review: Huadong Pharma Enters $662 Million Deal For 2 Kiniksa Anti-Inflammatory Drugs
Sun, Feb. 27 IVBIY, KNSA, SMHGF
Week In Review: China's NMPA Approves Pfizer's Oral COVID-19 Therapy Paxlovid
Sun, Feb. 20 GRCL, IVBIY, LEGN1 Comment
Week In Review: U.S. FDA Rejects Innovent/Lilly PD-1 NDA Based On China-Only Trial Subjects
Sun, Feb. 13 ASCLF, CSPHF, IVBIY
Week In Review: Biopharma Deals Slow During China New Year Week
Sun, Feb. 6 BNIGF, HCM, KNTPF
Week In Review: Xbiome Acquires Diabetic Foot Ulcer Therapy In $139 Million Deal
Sun, Jan. 30 CGPHF, IMAB
Week In Review: Mabwell Bio Raises $547 Million In Shanghai STAR IPO
Mon, Jan. 24 CSPHF, IVBIY, LLY
Week In Review: ChinaBio At China Showcase - The Golden Age For China Life Science Investing
Mon, Jan. 17 CHRS, IVBIY, SANA
Week In Review: China Biopharma Books $500 Million Of Deals To Start 2022
Sun, Jan. 9 CSPHF, SHJBF, SHPHF
Week In Review: Tasly Pharma Acquires Sutro ADC In $385 Million Deal
Mon, Jan. 3 CSPHF, KNTPF, STRO
Week In Review: BeiGene Out-Licenses TIGIT Inhibitor To Novartis In $2.8 Billion Pact
Dec. 27, 2021 BGNE, CSPHF, CYTK
Week In Review: BeiGene Completes $3.5 Billion IPO On Shanghai STAR Board
Dec. 20, 2021 BGNE, ABUS, HNSPF
Week In Review: BeiGene Raises $3.5 Billion In Shanghai STAR Board IPO
Dec. 5, 2021 BGNE, SFTBY, SFTBF
Week In Review: Shanghai's Zenas Acquires CD19 Antibody From Xencor In $480 Million Deal
Nov. 28, 2021 XNCR, BGNE, TCON
Week In Review: BeiGene Cleared To Stage $3 Billion IPO On Shanghai STAR Exchange
Nov. 21, 2021 BGNE, CNTB
Week In Review: Zai Lab Announces Two In-Licensings With Total Value Of $800 Million
Nov. 14, 2021 ZLAB, KRTX, IMAB
Week In Review: 2 China-Affiliated Biopharmas Raise $585 Million In IPOs
Nov. 7, 2021 BGNE, CHRS, KNTPF
Week In Review: Fosun Pharma Acquires Majority Stake In China Vaccine Company For $682 Million
Nov. 1, 2021 CRVS, IVBIY, PFE
Week In Review: China's Hansoh Signs 2 siRNA Deals Worth $1.7 Billion
Oct. 24, 2021 HNSPF, IMAB, IVBXF